This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

UK judge cites evidence of ZTE hold up, says expedited Frand trial warranted

By Melissa Ritti ( March 24, 2025, 20:59 GMT | Insight) -- A trial over fair, reasonable and nondiscriminatory, or Frand, terms for a cross-license to Samsung and ZTE cellular standard essential patent, or SEP, portfolios should take place sooner rather than later to short-circuit what “appears to be a determined campaign of hold up” by the Chinese telecom giant, UK High Court Judge James Mellor said today. In a written decision explaining his bench ruling earlier this month, Mellor said ZTE’s global pursuit of injunctive relief “is straight out of the overly aggressive SEP owner’s current playbook” — and that Samsung faces “substantial damage” if the UK case is not accelerated.Samsung has prevailed on its request for a January 2026 trial with ZTE over fair, reasonable and nondiscriminatory, or Frand, terms to a cross-license for patents purportedly essential to cellular connectivity....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections